3.0.0 6294 2023-01-11T13:42:15Z 2023-01-11T13:42:15Z House HR 2018-06-28 115 [Congressional Record Volume 164, Number 109 (Thursday, June 28, 2018)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. SHIMKUS:H.R. 6294.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3: To regulate Commerce withforeign Nations, and among the several States, and with theIndian Tribes.[Page H5977]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2018-06-28T13:04:25Z 2018-06-28 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2018-06-28 Introduced in House IntroReferral Intro-H 9 Library of Congress 2018-06-28 Introduced in House IntroReferral 1000 9 Library of Congress S000364 Rep. Shimkus, John [R-IL-15] JOHN SHIMKUS R IL M. 15 N C001097 Rep. Cárdenas, Tony [D-CA-29] Tony Cárdenas D CA 29 2018-06-28 True E000215 Rep. Eshoo, Anna G. [D-CA-18] ANNA ESHOO D CA G. 18 2018-07-24 False Health Advisory bodies Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy Government studies and investigations Health promotion and preventive care Infectious and parasitic diseases Intellectual property Licensing and registrations Prescription drugs Health 00 2018-06-28 Introduced in House 2019-08-20T18:49:34Z Re-Valuing Anti-Microbial Products Act of 2018 or the REVAMP Act

This bill amends the Federal Food, Drug, and Cosmetic Act to provide for an award of 12 additional months of market exclusivity to a drug manufacturer for a drug designated as a "priority antimicrobial product." (A priority antimicrobial product is intended to treat or prevent a disease attributable to a multi-drug resistant bacterial or fungal pathogen for which there is a critical unmet medical need.)

]]> REVAMP Act Display Title REVAMP Act Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of priority antimicrobial products through the award of a transferable exclusivity extension period, and for other purposes. Introduced in House IH Short Titles as Introduced REVAMP Act Short Titles as Introduced Re-Valuing Anti-Microbial Products Act of 2018 Introduced in House 2018-06-28T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115hr6294ih/xml/BILLS-115hr6294ih.xml 2018-06-28 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.